Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

Share Price is delayed by 15 minutes
Get Live Data
113.00    1.50 (1.35%)
Bid:
112.00
Ask:
114.00
Spread: 2.00 (1.786%)
Market Cap: £67.98m
IGP Live PriceLast checked at - London Stock Exchange

Intraday Intercede Share Chart

Board Changes

30 Jun 2022 07:00

RNS Number : 7245Q
Intercede Group PLC
30 June 2022
Ā 

30 June 2022

Intercede Group plc

Ā 

("Intercede", the "Group" or the "Company")

Ā 

Board Changes

Ā 

Intercede, the leading specialist in digital identity, credential management and secure mobility, is pleased to announce that Royston Hoggarth, Non-Executive Director of the Company will succeed Chuck Pol as the Company's Chairman. Chuck Pol has been Chairman for the last four years, during which time the Group has considerably strengthened its market position and is now well positioned for the future. Chuck will step back into a Non-Executive role with immediate effect.

Ā 

The Company is also delighted to announce the appointment of Tina Whitley as Independent Non-Executive Director with effect from 1 July 2022. Tina has over 30 years' experience across the information technology sector. She currently holds the position of CEO at NEC Software Solutions, a provider of specialist software and services for the public sector. Previously she was the Managing Director responsible for the Capita SIMS Further Education and Libraries businesses and, prior to Capita Group, she was Director of Operations at Convergys. She has extensive commercial, operational and technical experience.

Ā 

Intercede CEO Klaas van der Leest said:

Ā 

"I am delighted that Royston has elected to step up to the role of Chairman. Having worked with Royston for many years, I am looking forward to working more closely through the next phase of Intercede's strategic development. On behalf of the Board, I want to thank Chuck for his support and leadership as Chairman during what was a very challenging time for the Group."

Ā 

"We are delighted to announce Tina's appointment as Non-Executive Director. She brings extensive relevant experience which will be of great value as we look to execute our growth plans."

Ā 

Ā 

Ā 

ENQUIRIES

Ā 

Intercede Group plc

Tel. + 44 (0)1455 558111

Klaas van der Leest

CEO

Nitil Patel

CFO

Ā 

finnCap Ltd.

Tel. + 44 (0)20 7220 0500

Simon Hicks/Fergus Sullivan

Corporate Finance

Tim Redfern/Charlotte Sutcliffe

ECM

Ā 

Ā 

Ā 

Regulatory disclosures

Ā 

The following information regarding Tina Jane Whitley, aged 53, is disclosed under Schedule 2(g) of the AIM Rules for Companies:

Ā 

Current Directorships

Directorships held in past 5 years

APD Communications Limited

(None)

APD Mobile Data Limited

Ā 

Argon NPS (Holdings) Limited

Ā 

Argon NPS Limited

Ā 

Argon Topco Limited

Ā 

Charter Systems Limited

Ā 

Digital Healthcare Limited

Ā 

Garden Private Holdings Limited

Ā 

Health Information Systems (UK) Limited

Ā 

i2N Ltd

Ā 

Medical Imaging UK Limited

Ā 

MIDRSS Limited

Ā 

NEC Software Solutions ANZ Pty Limited

Ā 

NEC Software Solutions Canada Limited

Ā 

NEC Software Solutions India Pvt Limited

Ā 

NEC Software Solutions UK Limited

Ā 

Northgate Public Services Limited

Ā 

NPS (Holdings) Limited

Ā 

NPS (UK11) Limited

Ā 

NPS (UK13) Limited

Ā 

Rave Technologies (UK) Limited

Ā 

Rave Technologies USA Inc

Ā 

SX3 Limited

Ā 

Vantage Diagnostics Ltd

Ā 

Vantage Health Limited

Ā 

We Are Snook Limited

Ā 

Ā 

Ā 

Ā 

There are no other matters which are required to be announced under Schedule 2(g) of the AIM Rules for Companies.

Ā 

Ā 

About Intercede

Intercede is a cybersecurity company specialising in digital identities, derived credentials and access control, enabling digital trust in a mobile world.

Ā 

Headquartered in the UK, with offices in the US, we believe in a connected world in which people and technology are free to exchange information securely, and complex insecure passwords become a thing of the past.

Ā 

Our vision is to make the highest levels of cybersecurity available to organizations and consumers alike, solving complexity and scalability issues by managing high volumes of digital credentials.

Ā 

We have been delivering trusted solutions to high profile customers for over 20 years. Our team of experts has deployed millions of identities to governments, most of the largest aerospace and defence corporations, and major financial services and healthcare organizations, as well as leading telecommunications, cloud services and information technology firms, providing industry-leading employee and customer credential management systems.

For more information visit: www.intercede.com

Ā 

Ā 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the company's obligations under Article 17 of MAR.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Ā 
END
Ā 
Ā 
BOABKCBQCBKDOAB
Date   Source Headline
17th Dec 201810:19 amRNSBoard Change
26th Nov 20187:00 amRNSHalf-year Report
22nd Oct 20187:00 amRNSGrant of Options
4th Oct 20187:00 amRNSTrading Statement
20th Sep 20187:00 amRNSResult of AGM
4th Sep 20187:00 amRNSDirector/PDMR Shareholding
10th Aug 20187:00 amRNSDirector/PDMR Shareholding
31st Jul 20187:00 amRNSDirector/PDMR Shareholding
10th Jul 20188:00 amRNSDirector/PDMR Shareholding
29th Jun 20184:59 pmRNSPDMR Shareholding
7th Jun 20187:00 amRNSFinal Results
26th Apr 20182:10 pmRNSPDMR Change
25th Apr 20187:00 amRNSDirector/PDMR Shareholding
20th Apr 201812:15 pmRNSPDMR Change
11th Apr 201811:36 amRNSHolding(s) in Company
11th Apr 20187:00 amRNSAppointment of Chief Executive
4th Apr 20187:00 amRNSReceipt of $4.0m Order/Trading Update
29th Mar 20187:00 amRNSDirectorate Change
9th Mar 20187:00 amRNSNew Contract Award
13th Feb 20187:00 amRNSNew Contract Award
4th Dec 20177:00 amRNSContract
30th Nov 20177:00 amRNSNew Contract Award
27th Nov 20177:00 amRNSHalf-year Report
6th Nov 20171:58 pmRNSTrading Update
26th Oct 20177:00 amRNSShare Award
5th Oct 20177:00 amRNSTrading Statement
13th Sep 20173:30 pmRNSResult of AGM
13th Sep 20177:00 amRNSDirectorate Change
25th Aug 20177:00 amRNSIssue of Convertible Loan Notes
1st Aug 20179:07 amRNSTotal Voting Rights
27th Jul 20177:00 amRNSShare Incentive Plan & Issue of Equity
18th Jul 20177:00 amRNSDirector/PDMR Shareholding & TVR
13th Jun 20177:00 amRNSCollaborations with VMWare and Imagination
7th Jun 201712:06 pmRNSHolding(s) in Company
7th Jun 201712:01 pmRNSHolding(s) in Company
7th Jun 20177:00 amRNSFinal Results
6th Jun 20177:00 amRNSLaunch of MyIDaaS
25th May 20177:00 amRNSSchedule 2(g) Disclosure
23rd May 20177:00 amRNSAppointment of Chief Sales Officer
17th May 20177:00 amRNSNon-Executive Director Appointment
9th May 20177:00 amRNSContract Win
8th May 20173:45 pmRNSShare Incentive Plan
8th May 20177:00 amRNSIntercede announces Secure Login for WordPress
5th Apr 20177:00 amRNSTrading Update
31st Mar 20177:00 amRNSListing of Convertible Loan Notes
20th Mar 20177:00 amRNSAppointment of VP, US Gov't & Enterprise Sales
15th Mar 20173:03 pmRNSShare Incentive Plan
9th Mar 20177:00 amRNSAppointment of Adviser
3rd Mar 20177:00 amRNSTrading Update
27th Jan 201712:15 pmRNSResult of General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.